KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) Equity Average (2016 - 2026)

Historic Equity Average for Exelixis (EXEL) over the last 16 years, with Q1 2026 value amounting to $2.2 billion.

  • Exelixis' Equity Average fell 437.21% to $2.2 billion in Q1 2026 from the same period last year, while for Jan 2026 it was $2.2 billion, marking a year-over-year decrease of 437.21%. This contributed to the annual value of $2.2 billion for FY2026, which is 227.57% down from last year.
  • Per Exelixis' latest filing, its Equity Average stood at $2.2 billion for Q1 2026, which was down 437.21% from $2.1 billion recorded in Q4 2025.
  • In the past 5 years, Exelixis' Equity Average ranged from a high of $2.5 billion in Q2 2023 and a low of $2.1 billion during Q3 2025
  • For the 5-year period, Exelixis' Equity Average averaged around $2.3 billion, with its median value being $2.3 billion (2022).
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 1884.19% in 2022, then crashed by 1643.36% in 2024.
  • Exelixis' Equity Average (Quarter) stood at $2.5 billion in 2022, then fell by 7.4% to $2.3 billion in 2023, then dropped by 4.69% to $2.2 billion in 2024, then dropped by 4.57% to $2.1 billion in 2025, then increased by 3.05% to $2.2 billion in 2026.
  • Its Equity Average was $2.2 billion in Q1 2026, compared to $2.1 billion in Q4 2025 and $2.1 billion in Q3 2025.